The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
Lonza will take on technology transfer, process optimization, and cGMP manufacturing, leveraging its global network and expertise in highly potent compounds
UK Prime Minister Keir Starmer praised the initiative, saying: “Unlocking opportunities for British businesses across the globe and delivering for working people back home is always the driving force behind my international engagements."
Collaboration funds participating biotechs to access Lilly predictive models through the Revvity Signals Xynthetica offering
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
The deal reinforces GSK’s leadership in respiratory care and builds upon the company’s expanding COPD portfolio
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
